Global Women Health Diagnostics Market 2022-2028

Description

List of Tables

Global Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period (2022-2028)

The global women health diagnosticsmarket is anticipated to grow at a substantial CAGR of 7.9% during the forecast period.The major factor propelling the growth of the market includes the rapidly rising rate of obesity across the globe, especially among women. Women suffer from certain diseases and disorders mostly related to menstrual disorders, osteoporosis, obesity, ovarian cancer, breast cancer, pregnancy and childbirth, and mammography. The key factors that are contributing to the growth of the global women health diagnostics market include numerous government initiatives to promote women health awareness, increasing adoption of diagnostics imaging procedures and demand for point-of-care diagnostic testing. However, the high cost of a dearth of skilled professionals and diagnostics tests acts as a restraint in the growth of the global women health diagnostics market.

The global women health diagnostics market is segmented based on application and end-users. Based on application, the market is bifurcated into breast cancer testing, cervical cancer testing, pregnancy & fertility testing, ovarian cancer testing, infectious disease testing, ultrasound tests, sexually transmitted disease testing, and others. The other segment comprises osteoporosis testing and prenatal genetic testing. Further, based on the end-users, the market is sub-segmentedinto diagnostic and imaging centers, hospitals and clinics, and home care. Among the end-users, the hospitals & clinics segment is expected to grow at a significant CAGR over the forecast period owing to the availability of highly developed infrastructure along with efficient and effective medical equipment in hospitals. Moreover, the rising number of surgeries conducted within the hospitals is higher compared to diagnostic and imaingcenters.

Geographically the women health diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.Among these regions, North America is anticipated to hold a prominent market share across the globe, due to the rising prevalence of cancer and incidences of lifestyle-related disorders within the region. In the US, breast cancer death rates in women are higher than those for any other cancer besides lung cancer. According to Breastcancer.org, in 2020, around 43,780 mortalities of breast cancer were registered in the US. Moreover, the rising demand for fertility testing monitors and the growing focus of women health diagnostic product manufacturers on expanding their presence within the regional boundaries are also playing a vital role in the growth of the region. Furthermore, Asia-Pacific is expected to exhibit a considerable growth rate in the global market during the forecast period. This is owing to the rising awareness among women related to several health disorders and increasing proportionately incomes.

The major companies serving the global women health diagnosticsmarket areAbbott Laboratories, Inc., Becton, Dickinson and Co., BiomerieuxSA, DIALAB Gmbh,EKF Diagnostics Holdings PLC,and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2021, EKF Diagnostics acquired ADL Health's molecular diagnostic testing laboratory. Through thisacquisition, the company aims to enhance and improveitsbroad range of diagnostic products and services, including a testing offering.

Research Methodology

The market study of the global women health diagnosticsmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, researchpapers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Women health diagnosticsMarket Research and Analysis by Application.

2. Global Women health diagnosticsMarket Research and Analysis by End-Users.

The Report Covers

Comprehensive research methodology of the globalwomen health diagnosticsmarket.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global women health diagnosticsmarket.
Insights about market determinants that are stimulating the global women health diagnosticsmarket.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: MD-1228

Category- Medical Devices

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Women Health Diagnostics Market
Recovery Scenario of Global Women Health DiagnosticsMarket
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. ByRegion

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key CompanyAnalysis
- 3.1.1. Abbott Laboratories, Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Becton, Dickinson, and Co.
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. General Electric Co.
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
- 3.1.4. Quest Diagnostics Inc.

Overview

3.1.4.1. Financial Analysis
3.1.4.2. SWOT Analysis
3.1.4.3. Recent Developments

3.1.5. Siemens AG
- 3.1.5.1. Overview
- 3.1.5.2. Financial Analysis
- 3.1.5.3. SWOT Analysis
- 3.1.5.4. Recent Developments

3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Women Health Diagnostics Market by Application
- 4.1.1. Breast Cancer Testing
- 4.1.2. Cervical Cancer Testing
- 4.1.3. Pregnancy & Fertility Testing
- 4.1.4. Ovarian Cancer Testing
- 4.1.5. Infectious Disease Testing
- 4.1.6. Ultrasound Tests
- 4.1.7. Sexually Transmitted Disease Testing
- 4.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
4.2. Global Women Health DiagnosticsMarket by End-Users
- 4.2.1. Diagnostic and Imaging Centers
- 4.2.2. Hospitals and Clinics
- 4.2.3. Home Care

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. BiomerieuxSA
6.2. DIALAB GmbH
6.3. EKF Diagnostics Holdings PLC
6.4. F. Hoffmann-La Roche Ltd.
6.5. Fujifilm Holdings Corp.
6.6. GenMark Diagnostics, Inc.
6.7. Hologic, Inc.
6.8. Koninklijke Philips N.V.
6.9. Luminex Corp.
6.10. Nova Biomedical Pte. Ltd.
6.11. PerkinElmer Inc.
6.12. QIAGEN N.V.
6.13. Somagen Diagnostics Inc.
6.14. Thermo Fisher Scientific Inc.
6.15. Trinity Biotech PLC